trending Market Intelligence /marketintelligence/en/news-insights/trending/BQ80_Q3PEZJZqzV-fEVhPw2 content esgSubNav
In This List

US FDA clears Spectral Medical's stand-alone pump

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


US FDA clears Spectral Medical's stand-alone pump

The U.S. Food and Drug Administration granted 510(k) clearance to Spectral Medical Inc.'s Spectral Apheresis Machine.

The machine is intended for use in continuous renal replacement therapy and therapeutic plasma exchange.